Industry Research Reports
Home > Reports > Pharma & Healthcare > Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Paliperidone Palmitate Long-Acting Injection Market Size(US$)
CAGR 2025-2031
6.3%
Market Size,2031
USD 6,283
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 4,355 million
Market Forecast in 2031(Value)
US$ 6,283 million
CAGR
6.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Paliperidone palmitate long-acting injection is a sustained-release antipsychotic injection, the main ingredient of which is paliperidone palmitate, a long-acting esterified form of paliperidone. The preparation is administered by intramuscular injection and can gradually hydrolyze and release active drugs in the body to achieve a sustained therapeutic effect. It is usually injected once a month for the treatment of schizophrenia and related mental disorders, which helps to improve patient compliance, reduce the risk of relapse and improve treatment stability.
North American market for Paliperidone Palmitate Long-Acting Injection was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Paliperidone Palmitate Long-Acting Injection was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Paliperidone Palmitate Long-Acting Injection was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Paliperidone Palmitate Long-Acting Injection include Janssen Pharmaceuticals, Teva Pharmaceutical, Viatris, Sun Pharmaceutical, Cipla, Hikma Pharmaceuticals, Qilu Pharmaceutical, Hansoh Pharmaceuticak Group, Luye Pharma Group, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Paliperidone Palmitate Long-Acting Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Paliperidone Palmitate Long-Acting Injection by region & country, by Type, and by Application.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Paliperidone Palmitate Long-Acting Injection cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Paliperidone Palmitate Long-Acting Injection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paliperidone Palmitate Long-Acting Injection.
Market Segmentation
By Company
- Janssen Pharmaceuticals
- Teva Pharmaceutical
- Viatris
- Sun Pharmaceutical
- Cipla
- Hikma Pharmaceuticals
- Qilu Pharmaceutical
- Hansoh Pharmaceuticak Group
- Luye Pharma Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Monthly Dosage Form
- Quarterly Dosage Form
Segment by Application
- General Hospital
- Specialized Hospital
- Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Paliperidone Palmitate Long-Acting Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Paliperidone Palmitate Long-Acting Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Paliperidone Palmitate Long-Acting Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Paliperidone Palmitate Long-Acting Injection Product Introduction
1.2 Global Paliperidone Palmitate Long-Acting Injection Market Size Forecast
1.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value (2020-2031)
1.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume (2020-2031)
1.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Price (2020-2031)
1.3 Paliperidone Palmitate Long-Acting Injection Market Trends & Drivers
1.3.1 Paliperidone Palmitate Long-Acting Injection Industry Trends
1.3.2 Paliperidone Palmitate Long-Acting Injection Market Drivers & Opportunity
1.3.3 Paliperidone Palmitate Long-Acting Injection Market Challenges
1.3.4 Paliperidone Palmitate Long-Acting Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Paliperidone Palmitate Long-Acting Injection Players Revenue Ranking (2024)
2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
2.3 Global Paliperidone Palmitate Long-Acting Injection Players Sales Volume Ranking (2024)
2.4 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Company Players (2020-2025)
2.5 Global Paliperidone Palmitate Long-Acting Injection Average Price by Company (2020-2025)
2.6 Key Manufacturers Paliperidone Palmitate Long-Acting Injection Manufacturing Base and Headquarters
2.7 Key Manufacturers Paliperidone Palmitate Long-Acting Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Paliperidone Palmitate Long-Acting Injection
2.9 Paliperidone Palmitate Long-Acting Injection Market Competitive Analysis
2.9.1 Paliperidone Palmitate Long-Acting Injection Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Paliperidone Palmitate Long-Acting Injection Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone Palmitate Long-Acting Injection as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monthly Dosage Form
3.1.2 Quarterly Dosage Form
3.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type
3.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Type (2020-2031)
3.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Type (%) (2020-2031)
3.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type
3.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Type (2020-2031)
3.3.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Type (%) (2020-2031)
3.4 Global Paliperidone Palmitate Long-Acting Injection Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 General Hospital
4.1.2 Specialized Hospital
4.1.3 Others
4.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application
4.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Application (2020-2031)
4.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value, by Application (%) (2020-2031)
4.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application
4.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Application (2020-2031)
4.3.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume, by Application (%) (2020-2031)
4.4 Global Paliperidone Palmitate Long-Acting Injection Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region
5.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2020-2025)
5.1.3 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2026-2031)
5.1.4 Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), (2020-2031)
5.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region
5.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2020-2025)
5.2.3 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2026-2031)
5.2.4 Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (%), (2020-2031)
5.3 Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
5.4.2 North America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
5.5.2 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
5.6.2 Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
5.7.2 South America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
5.8.2 Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value and Sales Volume
6.2.1 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.2.2 Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.3.2 United States Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.4.2 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.5.2 China Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.5.3 China Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.6.2 Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.7.2 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.8.2 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Paliperidone Palmitate Long-Acting Injection Sales Value, 2020-2031
6.9.2 India Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
6.9.3 India Paliperidone Palmitate Long-Acting Injection Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Janssen Pharmaceuticals
7.1.1 Janssen Pharmaceuticals Company Information
7.1.2 Janssen Pharmaceuticals Introduction and Business Overview
7.1.3 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
7.1.5 Janssen Pharmaceuticals Recent Development
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Information
7.2.2 Teva Pharmaceutical Introduction and Business Overview
7.2.3 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.2.5 Teva Pharmaceutical Recent Development
7.3 Viatris
7.3.1 Viatris Company Information
7.3.2 Viatris Introduction and Business Overview
7.3.3 Viatris Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Viatris Paliperidone Palmitate Long-Acting Injection Product Offerings
7.3.5 Viatris Recent Development
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Information
7.4.2 Sun Pharmaceutical Introduction and Business Overview
7.4.3 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.4.5 Sun Pharmaceutical Recent Development
7.5 Cipla
7.5.1 Cipla Company Information
7.5.2 Cipla Introduction and Business Overview
7.5.3 Cipla Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Cipla Paliperidone Palmitate Long-Acting Injection Product Offerings
7.5.5 Cipla Recent Development
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Company Information
7.6.2 Hikma Pharmaceuticals Introduction and Business Overview
7.6.3 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
7.6.5 Hikma Pharmaceuticals Recent Development
7.7 Qilu Pharmaceutical
7.7.1 Qilu Pharmaceutical Company Information
7.7.2 Qilu Pharmaceutical Introduction and Business Overview
7.7.3 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
7.7.5 Qilu Pharmaceutical Recent Development
7.8 Hansoh Pharmaceuticak Group
7.8.1 Hansoh Pharmaceuticak Group Company Information
7.8.2 Hansoh Pharmaceuticak Group Introduction and Business Overview
7.8.3 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product Offerings
7.8.5 Hansoh Pharmaceuticak Group Recent Development
7.9 Luye Pharma Group
7.9.1 Luye Pharma Group Company Information
7.9.2 Luye Pharma Group Introduction and Business Overview
7.9.3 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product Offerings
7.9.5 Luye Pharma Group Recent Development
8 Industry Chain Analysis
8.1 Paliperidone Palmitate Long-Acting Injection Industrial Chain
8.2 Paliperidone Palmitate Long-Acting Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Paliperidone Palmitate Long-Acting Injection Sales Model
8.5.2 Sales Channel
8.5.3 Paliperidone Palmitate Long-Acting Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Paliperidone Palmitate Long-Acting Injection Market Trends
Table 2. Paliperidone Palmitate Long-Acting Injection Market Drivers & Opportunity
Table 3. Paliperidone Palmitate Long-Acting Injection Market Challenges
Table 4. Paliperidone Palmitate Long-Acting Injection Market Restraints
Table 5. Global Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 7. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Company (2020-2025) & (K Dose)
Table 8. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Paliperidone Palmitate Long-Acting Injection Price by Company (2020-2025) & (US$/Dose)
Table 10. Key Manufacturers Paliperidone Palmitate Long-Acting Injection Manufacturing Base and Headquarters
Table 11. Key Manufacturers Paliperidone Palmitate Long-Acting Injection Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Paliperidone Palmitate Long-Acting Injection
Table 13. Global Paliperidone Palmitate Long-Acting Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone Palmitate Long-Acting Injection as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Type (2020-2025)
Table 20. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Type (2026-2031)
Table 21. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type: 2020 VS 2024 VS 2031 (K Dose)
Table 22. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (2020-2025) & (K Dose)
Table 23. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (2026-2031) & (K Dose)
Table 24. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Paliperidone Palmitate Long-Acting Injection Price by Type (2020-2025) & (US$/Dose)
Table 27. Global Paliperidone Palmitate Long-Acting Injection Price by Type (2026-2031) & (US$/Dose)
Table 28. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Application (2020-2025)
Table 32. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Value by Application (2026-2031)
Table 33. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application: 2020 VS 2024 VS 2031 (K Dose)
Table 34. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (2020-2025) & (K Dose)
Table 35. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (2026-2031) & (K Dose)
Table 36. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Paliperidone Palmitate Long-Acting Injection Price by Application (2020-2025) & (US$/Dose)
Table 39. Global Paliperidone Palmitate Long-Acting Injection Price by Application (2026-2031) & (US$/Dose)
Table 40. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2020-2025) & (%)
Table 44. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Region (2026-2031) & (%)
Table 45. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (K Dose): 2020 VS 2024 VS 2031
Table 46. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2020-2025) & (K Dose)
Table 47. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2026-2031) & (K Dose)
Table 48. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2020-2025) & (%)
Table 49. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Region (2026-2031) & (%)
Table 50. Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (2020-2025) & (US$/Dose)
Table 51. Global Paliperidone Palmitate Long-Acting Injection Average Price by Region (2026-2031) & (US$/Dose)
Table 52. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, (2020-2025) & (K Dose)
Table 56. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume, (2026-2031) & (K Dose)
Table 57. Janssen Pharmaceuticals Company Information
Table 58. Janssen Pharmaceuticals Introduction and Business Overview
Table 59. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 60. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 61. Janssen Pharmaceuticals Recent Development
Table 62. Teva Pharmaceutical Company Information
Table 63. Teva Pharmaceutical Introduction and Business Overview
Table 64. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 65. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 66. Teva Pharmaceutical Recent Development
Table 67. Viatris Company Information
Table 68. Viatris Introduction and Business Overview
Table 69. Viatris Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 70. Viatris Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 71. Viatris Recent Development
Table 72. Sun Pharmaceutical Company Information
Table 73. Sun Pharmaceutical Introduction and Business Overview
Table 74. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 75. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 76. Sun Pharmaceutical Recent Development
Table 77. Cipla Company Information
Table 78. Cipla Introduction and Business Overview
Table 79. Cipla Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Cipla Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 81. Cipla Recent Development
Table 82. Hikma Pharmaceuticals Company Information
Table 83. Hikma Pharmaceuticals Introduction and Business Overview
Table 84. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 85. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 86. Hikma Pharmaceuticals Recent Development
Table 87. Qilu Pharmaceutical Company Information
Table 88. Qilu Pharmaceutical Introduction and Business Overview
Table 89. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 91. Qilu Pharmaceutical Recent Development
Table 92. Hansoh Pharmaceuticak Group Company Information
Table 93. Hansoh Pharmaceuticak Group Introduction and Business Overview
Table 94. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 95. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 96. Hansoh Pharmaceuticak Group Recent Development
Table 97. Luye Pharma Group Company Information
Table 98. Luye Pharma Group Introduction and Business Overview
Table 99. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 100. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product Offerings
Table 101. Luye Pharma Group Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Paliperidone Palmitate Long-Acting Injection Downstream Customers
Table 105. Paliperidone Palmitate Long-Acting Injection Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Paliperidone Palmitate Long-Acting Injection Product Picture
Figure 2. Global Paliperidone Palmitate Long-Acting Injection Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Paliperidone Palmitate Long-Acting Injection Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Paliperidone Palmitate Long-Acting Injection Sales Volume (2020-2031) & (K Dose)
Figure 5. Global Paliperidone Palmitate Long-Acting Injection Sales Price (2020-2031) & (US$/Dose)
Figure 6. Paliperidone Palmitate Long-Acting Injection Report Years Considered
Figure 7. Global Paliperidone Palmitate Long-Acting Injection Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Paliperidone Palmitate Long-Acting Injection Players Sales Volume Ranking (2024) & (K Dose)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Paliperidone Palmitate Long-Acting Injection Revenue in 2024
Figure 10. Paliperidone Palmitate Long-Acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Monthly Dosage Form Picture
Figure 12. Quarterly Dosage Form Picture
Figure 13. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Paliperidone Palmitate Long-Acting Injection Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Type (2020 VS 2024 VS 2031) & (K Dose)
Figure 16. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Paliperidone Palmitate Long-Acting Injection Price by Type (2020-2031) & (US$/Dose)
Figure 18. Product Picture of General Hospital
Figure 19. Product Picture of Specialized Hospital
Figure 20. Product Picture of Others
Figure 21. Global Paliperidone Palmitate Long-Acting Injection Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Paliperidone Palmitate Long-Acting Injection Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Paliperidone Palmitate Long-Acting Injection Sales Volume by Application (2020 VS 2024 VS 2031) & (K Dose)
Figure 24. Global Paliperidone Palmitate Long-Acting Injection Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Paliperidone Palmitate Long-Acting Injection Price by Application (2020-2031) & (US$/Dose)
Figure 26. North America Paliperidone Palmitate Long-Acting Injection Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Paliperidone Palmitate Long-Acting Injection Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Paliperidone Palmitate Long-Acting Injection Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Paliperidone Palmitate Long-Acting Injection Sales Volume (%), (2020-2031)
Figure 38. United States Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 44. China Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 46. China Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 56. India Paliperidone Palmitate Long-Acting Injection Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Paliperidone Palmitate Long-Acting Injection Sales Value by Type (%), 2024 VS 2031
Figure 58. India Paliperidone Palmitate Long-Acting Injection Sales Value by Application (%), 2024 VS 2031
Figure 59. Paliperidone Palmitate Long-Acting Injection Industrial Chain
Figure 60. Paliperidone Palmitate Long-Acting Injection Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Related Reports
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 141
USD 4900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 83
USD 2900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 99
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 110
USD 2900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 147
USD 4900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 141
USD 4900.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 83
USD 2900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 99
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 110
USD 2900.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research